AP
ITCI

Atwood & Palmer’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Atwood & Palmer’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-600
Closed -$50.1K – 486
2024
Q4 		$50.1K Hold
600
– – ﹤0.01% 220
2024
Q3 		$43.9K Hold
600
– – ﹤0.01% 228
2024
Q2 		$41.1K Hold
600
– – ﹤0.01% 236
2024
Q1 		$41.5K Hold
600
– – ﹤0.01% 224
2023
Q4 		$43K Hold
600
– – ﹤0.01% 224
2023
Q3 		$31.3K Hold
600
– – ﹤0.01% 238
2023
Q2 		$38K Hold
600
– – ﹤0.01% 234
2023
Q1 		$32.5K Hold
600
– – ﹤0.01% 230
2022
Q4 		$31.8K Hold
600
– – ﹤0.01% 246
2022
Q3 		$28K Hold
600
– – ﹤0.01% 242
2022
Q2 		$34K Hold
600
– – ﹤0.01% 245
2022
Q1 		$37K Hold
600
– – ﹤0.01% 260
2021
Q4 		$31K Hold
600
– – ﹤0.01% 279
2021
Q3 		$22K Buy
+600
New +$20.9K ﹤0.01% 295
2018
Q1 		– Sell
-200
Closed -$3K – 303
2017
Q4 		$3K Hold
200
– – ﹤0.01% 273
2017
Q3 		$3K Hold
200
– – ﹤0.01% 279
2017
Q2 		$2K Hold
200
– – ﹤0.01% 306
2017
Q1 		$3K Hold
200
– – ﹤0.01% 276
2016
Q4 		$3K Hold
200
– – ﹤0.01% 311
2016
Q3 		$3K Hold
200
– – ﹤0.01% 305
2016
Q2 		$8K Buy
+200
New +$7.19K ﹤0.01% 265

Other funds holding ITCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Atwood & Palmer's ITCI Position: Q1 2025 in Review

Atwood & Palmer sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2025, closing a stake of 600 shares — an estimated $50.1K sold.

Atwood & Palmer first reported a position in ITCI in Q2 2016 and held it in 21 quarters. The position peaked at $50.1K in Q4 2024. 395 funds tracked by Wall St. Rank hold ITCI as of Q1 2025.

  • Atwood & Palmer reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2025 after selling out during the quarter.
  • Atwood & Palmer sold 600 Intra-Cellular Therapies Inc. shares in Q1 2025, an estimated $50.1K.
  • Atwood & Palmer first reported a position in Intra-Cellular Therapies Inc. in Q2 2016 and held it in 21 quarters.
  • Atwood & Palmer's Intra-Cellular Therapies Inc. position peaked at $50.1K in Q4 2024.
  • 395 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2025.

Based on Atwood & Palmer's 13F filing for Q1 2025, filed 15 Apr 2025.